Overall Technical outlook

Price Summary

NATCO Pharma Limited's stock started the year at 905.05, climbed to a high of 924.45, fell to 872.85, and closed -1.75% down at 889.25, with 2751932 shares traded on 2025-04-25.
Over the course of 52 weeks, the stock peaked at 1592.85 and hit a low of 746.5.
12 analysts forecast that the price of NATCOPHARM will range from 710.0 to 1675.0, with an average expected price near 1099.3334.

Technicals

Support and Resistance: The price for NATCOPHARM at 889.25 is supported by the 821.9 level and faces resistance at 1146.35. This range indicates key levels where the price may find buyers near 821.9 and sellers near 1146.35, defining a trading range.
NATCOPHARM supportResistance ecdc6a
Support/Resistance for NATCOPHARM


Aroon: The AROON is currently neutral, showing no clear bias toward a rising or falling trend. This lack of directional clarity suggests that the market may be in a holding pattern, awaiting further developments.
NATCOPHARM aroon ecdc6a
Aroon chart for NATCO Pharma Limited


Bol. Bands: As the price falls below the upper Bollinger Band, it suggests a potential shift to a downward trend. This movement may indicate that the asset's recent uptrend is losing steam, prompting traders to anticipate a decline. Such a signal could be interpreted as a warning of an overbought condition, where the price correction is likely, making it a critical juncture for trading decisions.
NATCOPHARM bbands ecdc6a
Bolinger Bands chart for NATCO Pharma Limited


Parabolic SAR: The PSAR for NATCOPHARM continues to signal a bullish outlook, establishing a crucial support level that may help sustain the current upward momentum. This level of support suggests that the market is likely to continue trending higher, providing a foundation for ongoing bullish movement.
NATCOPHARM psar ecdc6a
Parabolic Stop and Reverse chart for NATCO Pharma Limited


Stochastic: The STOCHASTIC is currently in a neutral position for NATCO Pharma Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
NATCOPHARM stoch ecdc6a
Stochastic chart for NATCO Pharma Limited


Tripple Moving Agerage: The current reading of the Tripple MOVING AVG is neutral, offering no clear signals for a movement in either direction. This suggests that the market may be in a holding pattern, with no dominant trend in place.
NATCOPHARM trippleSMA ecdc6a
Tripple SMA chart for NATCO Pharma Limited


A comprehensive approach to analyzing a company requires considering both its technical and fundamental aspects. The company's fundamentals, such as its earnings, growth prospects, and financial health, provide a strong foundation for understanding technical indicators. Additionally, examining the industry it operates in helps contextualize the company's position within the broader market. By integrating these factors, one can gain more valuable insights into the company's stock performance and potential investment opportunities.